RIA
OMED

Regal Investment Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Regal Investment Advisors’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-313
Closed -$5K – 1094
2015
Q3 		$5K Buy
+313
New +$6.28K ﹤0.01% 824

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Regal Investment Advisors's OMED Position: Q4 2015 in Review

Regal Investment Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2015, closing a stake of 313 shares — an estimated $5K sold.

Regal Investment Advisors first reported a position in OMED in Q3 2015 and held it in 1 quarter. The position peaked at $5K in Q3 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

  • Regal Investment Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Regal Investment Advisors sold 313 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $5K.
  • Regal Investment Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Regal Investment Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $5K in Q3 2015.
  • 83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on Regal Investment Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.